SEC Form 4 · accession 0001209191-18-056944
NOVAVAX INC · NVAX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rachel K. King
Director
Period of report
Oct 31, 2018
Accepted (ET)
Nov 2, 2018 · 4:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001000694
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy)F1 | $1.76 | Oct 31, 2018 | A | 160,000 | A | Oct 31, 2019 | Oct 31, 2028 | Common Stock | 160,000 | 160,000 | D |
Explanation of responses
- F1One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended, will vest one (1) year from the October 31, 2018 grant date subject to continued service on the Company's Board of Directors through the vesting date.